Molecular signature of nitroso-redox balance in idiopathic dilated cardiomyopathies

Journal of the American Heart Association

Volumn 4, Issue 9, 2015, Pages

  Menazza, Sara ^a   Aponte, Angel ^a   Sun, Junhui ^a   Gucek, Marjan ^a   Steenbergen, Charles ^b   Murphy, Elizabeth ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Heart failure; nitroso redox signaling; Oxidation; S nitrosylation

Indexed keywords

CYTOCHROME C OXIDASE; GLUTATHIONE SYNTHASE; MALATE DEHYDROGENASE; MITOCHONDRIAL PROTEIN; NITRIC OXIDE SYNTHASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; NITROSO DERIVATIVE; NOS3 PROTEIN, HUMAN; PROTEIN;

ARTICLE; CARDIAC MUSCLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HEART FAILURE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MALE; NITROSYLATION; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEOMICS; SEX DIFFERENCE; ADULT; AGED; CASE CONTROL STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PROCEDURES; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; NITROSO COMPOUNDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEINS; PROTEOMICS; SEX FACTORS; TANDEM MASS SPECTROMETRY;

EID: 84991521042     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.002251     Document Type: Article

References (47)

1. Sanbe A. Dilated cardiomyopathy: a disease of the myocardium. Biol Pharm Bull. 2013;36:18-22.
2. Morales A, Hershberger RE. Genetic evaluation of dilated cardiomyopathy. Curr Cardiol Rep. 2013;15:375.
3. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296:1867-1876.
4. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 2005;115:500-508.
5. Saraiva RM, Hare JM. Nitric oxide signaling in the cardiovascular system:implications for heart failure. Curr Opin Cardiol. 2006;21:221-228.
6. Hafstad AD, Nabeebaccus AA, Shah AM. Novel aspects of ros signalling in heart failure. Basic Res Cardiol. 2013;108:359.
7. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315-424.
8. Zimmet JM, Hare JM. Nitroso-redox interactions in the cardiovascular system. Circulation. 2006;114:1531-1544.
9. Zhang Y, Tocchetti CG, Krieg T, Moens AL. Oxidative and nitrosative stress in the maintenance of myocardial function. Free Radic Biol Med. 2012;53:1531-1540.
10. Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy:mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther. 2014;142:372-415.
11. Rosenbaugh EG, Savalia KK, Manickam DS, Zimmerman MC. Antioxidantbased therapies for angiotensin II-associated cardiovascular diseases. Am J Physiol Regul Integr Comp Physiol. 2013;304:R917-R928.
12. Li Q, Bolli R, Qiu Y, Tang XL, Guo Y, French BA. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation. 2001;103:1893-1898.
13. Ye Y, Li J, Yuan Z. Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One. 2013;8:e56803.
14. Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart. 2007;93:903-907.
15. Kohler AC, Sag CM, Maier LS. Reactive oxygen species and excitationcontraction coupling in the context of cardiac pathology. J Mol Cell Cardiol. 2014;73:92-102.
16. Simon JN, Duglan D, Casadei B, Carnicer R. Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease. J Mol Cell Cardiol. 2014;73:80-91.
17. Canton M, Menazza S, Sheeran FL, Polverino de Laureto P, Di LF, Pepe S. Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol. 2011;57:300-309
18. Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D, Chen K, Gabrielson KL, Blakely RD, Shih JC, Pacak K, Kass DA, Di Lisa F, Paolocci N. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res. 2010;106:193-202.
19. Zhang M, Shah AM. Ros signalling between endothelial cells and cardiac cells. Cardiovasc Res. 2014;102:249-257.
20. Schulman IH, Hare JM. Regulation of cardiovascular cellular processes by S-nitrosylation. Biochim Biophys Acta. 2012;1820:752-762.
21. Karantalis V, Schulman IH, Hare JM. Nitroso-redox imbalance affects cardiac structure and function. J Am Coll Cardiol. 2013;61:933-935.
22. Tang L, Wang H, Ziolo MT. Targeting nos as a therapeutic approach for heart failure. Pharmacol Ther. 2014;142:306-315.
23. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH. Protein Snitrosylation:a physiological signal for neuronal nitric oxide. Nat Cell Biol. 2001;3:193-197.
24. Sun J, Morgan M, Shen RF, Steenbergen C, Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res. 2007;101:1155-1163.
25. Kohr MJ, Evangelista AM, Ferlito M, Steenbergen C, Murphy E. S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death. J Mol Cell Cardiol. 2014;69:67-74.
26. Hara MR, Thomas B, Cascio MB, Bae BI, Hester LD, Dawson VL, Dawson TM, Sawa A, Snyder SH. Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc Natl Acad Sci U S A. 2006;103:3887-3889.
27. Kohr MJ, Sun J, Aponte A, Wang G, Gucek M, Murphy E, Steenbergen C. Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture. Circ Res. 2011;108:418-426.
28. Sun J, Murphy E. Protein S-nitrosylation and cardioprotection. Circ Res. 2010;106:285-296.
29. Sun J, Picht E, Ginsburg KS, Bers DM, Steenbergen C, Murphy E. Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res. 2006;98:403-411.
30. Wang G, Wu WW, Zeng W, Chou CL, Shen RF. Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: reproducibility, linearity, and application with complex proteomes. J Proteome Res. 2006;5:1214-1223.
31. Jaffrey SR, Snyder SH. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE. 2001;2001:p11
32. Tong G, Aponte AM, Kohr MJ, Steenbergen C, Murphy E, Sun J. Postconditioning leads to an increase in protein S-nitrosylation. Am J Physiol Heart Circ Physiol. 2014;306:H825-H832.
33. Huigsloot M, Nijtmans LG, Szklarczyk R, Baars MJ, van den Brand MA, Hendriksfranssen MG, van den Heuvel LP, Smeitink JA, Huynen MA, Rodenburg RJ. A mutation in C2orf64 causes impaired cytochrome c oxidase assembly and mitochondrial cardiomyopathy. Am J Hum Genet. 2011;88:488-493.
34. Lin J, Steenbergen C, Murphy E, Sun J. Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation. 2009;120:245-254.
35. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93:1087-1094.
36. Ago T, Matsushima S, Kuroda J, Zablocki D, Kitazono T, Sadoshima J. The NADPH oxidase NOX4 and aging in the heart. Aging. 2010;2:1012-1016.
37. Sciarretta S, Yee D, Ammann P, Nagarajan N, Volpe M, Frati G, Sadoshima J. Role of NADPH oxidase in the regulation of autophagy in cardiomyocytes. Clin Sci. 2015;128:387-403.
38. Moens AL, Takimoto E, Tocchetti CG, Chakir K, Bedja D, Cormaci G, Ketner EA, Majmudar M, Gabrielson K, Halushka MK, Mitchell JB, Biswal S, Channon KM, Wolin MS, Alp NJ, Paolocci N, Champion HC, Kass DA. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin:efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation. 2008;117:2626-2636.
39. Hare JM, Stamler JS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest. 2005;115:509-517.
40. Carnicer R, Crabtree MJ, Sivakumaran V, Casadei B, Kass DA. Nitric oxide synthases in heart failure. Antioxid Redox Signal. 2013;18:1078-1099.
41. Kass DA, Shah AM. Redox and nitrosative regulation of cardiac remodeling. Antioxid Redox Signal. 2013;18:1021-1023.
42. Kohr MJ, Murphy E, Steenbergen C. Glyceraldehyde-3-phosphate dehydrogenase acts as a mitochondrial trans-S-nitrosylase in the heart. PLoS One. 2014;9:e111448.
43. Sun J, Kohr MJ, Nguyen T, Aponte AM, Connelly PS, Esfahani SG, Gucek M, Daniels MP, Steenbergen C, Murphy E. Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins. Antioxid Redox Signal. 2012;16:45-56.
44. Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, James AM, Cocheme HM, Reinhold J, Lilley KS, Partridge L, Fearnley IM, Robinson AJ, Hartley RC, Smith RA, Krieg T, Brookes PS, Murphy MP. Cardioprotection by Snitrosation of a cysteine switch on mitochondrial complex I. Nat Med. 2013;19:753-759.
45. Gucek M, Murphy E. What can we learn about carioprotection from the cardiac mitochondrial proteome. Cardiovasc Res. 2010;88:211-218.
46. Fu C, Wu C, Ago T, Zhai P, Sadoshima J, Li H. Quantitiative analysis of redoxsensitive proteome with DIGE and ICAT. Mol. Cell Proteomics. 2009;8:1674-1687.
47. Derakhshan B, Wille PC, Gross SS. Unbiased identification of cysteine S-nitrosylation sites on proteins. Nat Protoc. 2007;2:1685-1691.